Amyloid plaque core protein in Alzheimer disease and Down syndrome - PubMed (original) (raw)
Amyloid plaque core protein in Alzheimer disease and Down syndrome
C L Masters et al. Proc Natl Acad Sci U S A. 1985 Jun.
Abstract
We have purified and characterized the cerebral amyloid protein that forms the plaque core in Alzheimer disease and in aged individuals with Down syndrome. The protein consists of multimeric aggregates of a polypeptide of about 40 residues (4 kDa). The amino acid composition, molecular mass, and NH2-terminal sequence of this amyloid protein are almost identical to those described for the amyloid deposited in the congophilic angiopathy of Alzheimer disease and Down syndrome, but the plaque core proteins have ragged NH2 termini. The shared 4-kDa subunit indicates a common origin for the amyloids of the plaque core and of the congophilic angiopathy. There are superficial resemblances between the solubility characteristics of the plaque core and some of the properties of scrapie infectivity, but there are no similarities in amino acid sequences between the plaque core and scrapie polypeptides.
Similar articles
- Amyloid of neurofibrillary tangles of Guamanian parkinsonism-dementia and Alzheimer disease share identical amino acid sequence.
Guiroy DC, Miyazaki M, Multhaup G, Fischer P, Garruto RM, Beyreuther K, Masters CL, Simms G, Gibbs CJ Jr, Gajdusek DC. Guiroy DC, et al. Proc Natl Acad Sci U S A. 1987 Apr;84(7):2073-7. doi: 10.1073/pnas.84.7.2073. Proc Natl Acad Sci U S A. 1987. PMID: 3470778 Free PMC article. - Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.
Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K. Masters CL, et al. EMBO J. 1985 Nov;4(11):2757-63. doi: 10.1002/j.1460-2075.1985.tb04000.x. EMBO J. 1985. PMID: 4065091 Free PMC article. - Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
Tagliavini F, Giaccone G, Linoli G, Frangione B, Bugiani O. Tagliavini F, et al. Prog Clin Biol Res. 1989;317:1001-5. Prog Clin Biol Res. 1989. PMID: 2532368 - Genetics of the Alzheimer amyloid protein precursor.
Neve RL. Neve RL. Adv Exp Med Biol. 1990;265:291-9. doi: 10.1007/978-1-4757-5876-4_28. Adv Exp Med Biol. 1990. PMID: 2143050 Review. No abstract available. - Neuronal origin of cerebral amyloidogenic proteins: their role in Alzheimer's disease and unconventional virus diseases of the nervous system.
Masters CL, Beyreuther K. Masters CL, et al. Ciba Found Symp. 1987;126:49-64. doi: 10.1002/9780470513422.ch4. Ciba Found Symp. 1987. PMID: 3556089 Review.
Cited by
- The interplay of age, gender and amyloid on brain and cognition in mid-life and older adults.
Borne L, Thienel R, Lupton MK, Guo C, Mosley P, Behler A, Giorgio J, Adam R, Ceslis A, Bourgeat P, Fazlollahi A, Maruff P, Rowe CC, Masters CL, Fripp J, Robinson GA, Breakspear M. Borne L, et al. Sci Rep. 2024 Nov 8;14(1):27207. doi: 10.1038/s41598-024-78308-3. Sci Rep. 2024. PMID: 39516511 - Brain aging and Alzheimer's disease, a perspective from non-human primates.
Isidro F. Isidro F. Aging (Albany NY). 2024 Oct 29;16(20):13145-13171. doi: 10.18632/aging.206143. Epub 2024 Oct 29. Aging (Albany NY). 2024. PMID: 39475348 Free PMC article. Review. - Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)-Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems.
Scuteri D, Pierobon D, Pagliaro M, Hamamura K, Hayashi T, Pignolo L, Nicotera P, Bagetta G, Corasaniti MT. Scuteri D, et al. Pharmaceutics. 2024 Sep 27;16(10):1253. doi: 10.3390/pharmaceutics16101253. Pharmaceutics. 2024. PMID: 39458585 Free PMC article. - Amyloid-β (Aβ) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer's disease.
Taylor X, Noristani HN, Fitzgerald GJ, Oluoch H, Babb N, McGathey T, Carter L, Hole JT, Lacor PN, DeMattos RB, Wang Y. Taylor X, et al. Mol Neurodegener. 2024 Oct 21;19(1):77. doi: 10.1186/s13024-024-00758-0. Mol Neurodegener. 2024. PMID: 39434125 Free PMC article. - Heparin-enriched plasma proteome is significantly altered in Alzheimer's disease.
Guo Q, Ping L, Dammer EB, Duong DM, Yin L, Xu K, Shantaraman A, Fox EJ, Golde TE, Johnson ECB, Roberts BR, Lah JJ, Levey AI, Seyfried NT. Guo Q, et al. Mol Neurodegener. 2024 Oct 8;19(1):67. doi: 10.1186/s13024-024-00757-1. Mol Neurodegener. 2024. PMID: 39380021 Free PMC article.
References
- Acta Neuropathol. 1981;54(1):63-74 - PubMed
- Brain. 1981 Sep;104(3):559-88 - PubMed
- Science. 1982 Mar 5;215(4537):1243-5 - PubMed
- Biochem Biophys Res Commun. 1984 Aug 16;122(3):1131-5 - PubMed
- Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical